Author Info: (1) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. (2) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. (3)

Author Info: (1) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. (2) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. (3) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. (4) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. (5) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. (6) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. (7) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. (8) Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. thomas.duhen@providence.org.

Author Info: (1) Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan. Laboratory of Immunoparasitology, WPI Immunology Frontier Re

Author Info: (1) Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan. Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. (2) Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan. Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. (3) Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan. Laboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. (4) Genome Information Research Center, Osaka University, Suita, Osaka, Japan. (5) Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan. Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. Department of Immunoparasitology, Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, Japan. Center for Advances Modalities and Drug Delivery Systems, Osaka University, Suita, Osaka, Japan. (6) Laboratory of Experimental Immunology, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. (7) Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan. Laboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. Center for Advances Modalities and Drug Delivery Systems, Osaka University, Suita, Osaka, Japan. Department of Immunochemistry, Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, Japan. (8) Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan. Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. Department of Immunoparasitology, Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka, Japan. Center for Advances Modalities and Drug Delivery Systems, Osaka University, Suita, Osaka, Japan.

Author Info: (1) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France. (2) Im

Author Info: (1) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France. (2) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. (3) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. (4) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France. (5) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France. (6) Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France. (7) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. (8) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France. (9) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. (10) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. (11) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France. (12) Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France. (13) Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France. (14) Mnemo Therapeutics, Paris, France. (15) Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA. Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA. (16) Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA. Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA. (17) Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA. Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA. (18) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. (19) Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. sebastian.amigorena@curie.fr. CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France. sebastian.amigorena@curie.fr. Mnemo Therapeutics, Paris, France. sebastian.amigorena@curie.fr. (20) Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France. Laurie.MENGER@gustaveroussy.fr.

Author Info: (1) La Jolla Institute for Immunology, La Jolla, CA, USA. (2) La Jolla Institute for Immunology, La Jolla, CA, USA. (3) San Diego Supercomputer Center, University of California, La

Author Info: (1) La Jolla Institute for Immunology, La Jolla, CA, USA. (2) La Jolla Institute for Immunology, La Jolla, CA, USA. (3) San Diego Supercomputer Center, University of California, La Jolla, CA, USA. (4) La Jolla Institute for Immunology, La Jolla, CA, USA. (5) La Jolla Institute for Immunology, La Jolla, CA, USA. Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (6) La Jolla Institute for Immunology, La Jolla, CA, USA. (7) La Jolla Institute for Immunology, La Jolla, CA, USA. Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. (8) La Jolla Institute for Immunology, La Jolla, CA, USA. Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (9) Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (10) La Jolla Institute for Immunology, La Jolla, CA, USA. (11) Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (12) Immunology Center of Georgia, Augusta University, Augusta, GA, USA. (13) La Jolla Institute for Immunology, La Jolla, CA, USA. (14) La Jolla Institute for Immunology, La Jolla, CA, USA. (15) La Jolla Institute for Immunology, La Jolla, CA, USA. kley@augusta.edu. Immunology Center of Georgia, Augusta University, Augusta, GA, USA. kley@augusta.edu.

Author Info: (1) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University,

Author Info: (1) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (2) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (3) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (4) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (5) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (6) Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080. (7) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (8) Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (9) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (10) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (11) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. Harvard Program in Biophysics, Harvard University, Cambridge, MA 02138. (12) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215. (13) Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva CH-1211, Switzerland. Ludwig Institute for Cancer Research, Lausanne CH-1005, Switzerland. Agora Cancer Center, Lausanne CH-1005, Switzerland. (14) Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080. Department of Neurological Surgery, University of California, San Francisco, CA (15) Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080. (16) John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02215.

Author Info: (1) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA; The David Rockefeller Graduate Program, Rock

Author Info: (1) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA; The David Rockefeller Graduate Program, Rockefeller University, New York, NY 10065, USA. Electronic address: oogishi-tky@umin.ac.jp. (2) Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8303, Japan. (3) Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia. (4) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (5) Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8303, Japan; Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN Yokohama Institute, Yokohama 230-0045, Japan. (6) Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8303, Japan. (7) Department of Clinical Immunology and Internal Medicine, Strasbourg University Hospital, INSERM UMR-S1109, 67000 Strasbourg, France. (8) Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia. (9) Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW 2052, Australia. (10) Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia. (11) Department of Human Immunology, Research Branch, Sidra Medicine, Doha, Qatar. (12) Center for Interventional Immunology, Diabetes Clinical Research Program, Benaroya Research Institute, Seattle, WA 98101, USA. (13) Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW 2052, Australia. (14) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (15) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA; Primary Immunodeficiencies Group, University of Antioquia UdeA, Medellin, Colombia; School of Microbiology, University of Antioquia UdeA, Medellin, Colombia. (16) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (17) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (18) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (19) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (20) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (21) Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France. (22) Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France. (23) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (24) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (25) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (26) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA. (27) Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France. (28) Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France. (29) McGill University Genome Center, Montreal, QC, Canada; McGill Research Centre on Complex Traits, Dahdaleh Institute of Genomic Medicine, Montreal, QC H3A 0G1, Canada; Department of Human Genetics, McGill University, Montreal, QC H3A 0G1, Canada. (30) Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. (31) Department of Human Immunology, Research Branch, Sidra Medicine, Doha, Qatar. (32) Department of Human Immunology, Research Branch, Sidra Medicine, Doha, Qatar. (33) Department of Pediatric Immunology, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey. (34) Center for Systems Immunology, Benaroya Research Institute, Seattle, WA 98101, USA. (35) Center for Systems Immunology, Benaroya Research Institute, Seattle, WA 98101, USA. (36) Department of Immunobiology, School of Immunobiology & Microbial Sciences, Kings' College London, London WC2R 2LS, UK. (37) Department of Pediatrics, Tohoku University Graduate School of Medicine, Sendai 980-0872, Japan. (38) Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. (39) Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. (40) Department of Immunology and Infectious Diseases, Sydney Children's Hospital, High Street, Randwick, NSW 2031, Australia; School of Women's and Children's Health, University of New South Wales, Sydney, NSW 2052, Australia; Clinical Immunogenomics Research Consortium Australasia (CIRCA), Darlinghurst, NSW 2010, Australia. (41) Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Clinical Immunogenomics Research Consortium Australasia (CIRCA), Darlinghurst, NSW 2010, Australia; Westmead Clinical School, The University of Sydney, Westmead, NSW 2145, Australia. (42) John Hunter Children's Hospital, Newcastle, NSW 2305, Australia. (43) Canterbury Health Laboratories, Christchurch 8140, New Zealand. (44) Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-0037, Japan. (45) Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo 160-0016, Japan. (46) Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo 650-0047, Japan. (47) Department of Immunobiology, School of Immunobiology & Microbial Sciences, Kings' College London, London WC2R 2LS, UK. (48) Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. (49) McGill Research Centre on Complex Traits, Dahdaleh Institute of Genomic Medicine, Montreal, QC H3A 0G1, Canada; Department of Biochemistry, McGill University, Montreal, QC H3A 0G1, Canada. (50) Department of Human Immunology, Research Branch, Sidra Medicine, Doha, Qatar; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar. (51) Center for Interventional Immunology, Diabetes Clinical Research Program, Benaroya Research Institute, Seattle, WA 98101, USA; Diabetes Clinical Research Program, Benaroya Research Institute, Seattle, WA 98101, USA. (52) Clinical and Biomedical Science, Faculty of Health and Life Sciences, University of Exeter, Exeter EX1 2ED, UK. (53) Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France. (54) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France; Center for the Study of Primary Immunodeficiencies, Necker Hospital for Sick Children Assistance Publique-H™pitaux de Paris (AP-HP), Paris, France. (55) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France. (56) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France. (57) Department of Clinical Immunology and Internal Medicine, Strasbourg University Hospital, INSERM UMR-S1109, 67000 Strasbourg, France. (58) Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW 2052, Australia; Clinical Immunogenomics Research Consortium Australasia (CIRCA), Darlinghurst, NSW 2010, Australia. (59) Clinical and Biomedical Science, Faculty of Health and Life Sciences, University of Exeter, Exeter EX1 2ED, UK. (60) Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8303, Japan; Department of Immuno-Oncology PDT, Kyoto University Graduate School of Medicine, Kyoto 606-8303, Japan. (61) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France. (62) Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto 606-8303, Japan. (63) St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 10065, USA; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; Paris CitŽ University, Imagine Institute, Paris, France; Department of Pediatrics, Necker Hospital for Sick Children, 75015 Paris, France; Howard Hughes Medical Institute, New York, NY 10065, USA. (64) Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW 2052, Australia; Clinical Immunogenomics Research Consortium Australasia (CIRCA), Darlinghurst, NSW 2010, Australia. Electronic address: s.tangye@garvan.org.au.

Author Info: (1) Explicyte Immuno-Oncology, Bordeaux, France. (2) Explicyte Immuno-Oncology, Bordeaux, France; Department of Medicine, Institut Bergonié, Bordeaux, France. (3) Department of Pat

Author Info: (1) Explicyte Immuno-Oncology, Bordeaux, France. (2) Explicyte Immuno-Oncology, Bordeaux, France; Department of Medicine, Institut Bergonié, Bordeaux, France. (3) Department of Pathology, University Hospital Centre of Nice, Nice, France. (4) Explicyte Immuno-Oncology, Bordeaux, France; Department of Medicine, Institut Bergonié, Bordeaux, France. (5) Explicyte Immuno-Oncology, Bordeaux, France; Department of Medicine, Institut Bergonié, Bordeaux, France. (6) Department of Medicine, Institut Bergonié, Bordeaux, France. (7) Department of Medicine, Institut Bergonié, Bordeaux, France. (8) Department of Medicine, Institut Bergonié, Bordeaux, France. (9) Department of Medicine, Institut Bergonié, Bordeaux, France. (10) Department of Medicine, Institut Bergonié, Bordeaux, France. (11) Department of Medicine, Institut Bergonié, Bordeaux, France. (12) Explicyte Immuno-Oncology, Bordeaux, France. (13) Explicyte Immuno-Oncology, Bordeaux, France. (14) Explicyte Immuno-Oncology, Bordeaux, France. (15) Department of Medicine, Institut Bergonié, Bordeaux, France. (16) Department of Pathology, Institut Bergonié, Bordeaux, France. (17) AstraZeneca, Rahway, NJ, USA. (18) AstraZeneca, Rahway, NJ, USA. (19) University of Copenhagen, Copenhagen, Denmark. (20) Clinique Marzet, Pau, France. (21) Centre Hospitalier de la Côte Basque, Bayonne, France. (22) Explicyte Immuno-Oncology, Bordeaux, France. (23) Department of Medicine, Institut Bergonié, Bordeaux, France. Electronic address: a.italiano@bordeaux.unicancer.fr.

Author Info: (1) Department of Molecular, Cellular and Developmental Biology, University of California, Los Angeles, Los Angeles, CA, USA. (2) Department of Urology, David Geffen School of Medi

Author Info: (1) Department of Molecular, Cellular and Developmental Biology, University of California, Los Angeles, Los Angeles, CA, USA. (2) Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. (3) Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. (4) Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. (5) Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA. (6) Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA. (7) Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. (8) Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. (9) Department of Molecular, Cellular and Developmental Biology, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA, USA. (10) Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. (11) Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. (12) Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. (13) Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; The VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA. (14) Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: arnoldchin@mednet.ucla.edu.

Author Info: (1) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (2) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (3) Innate Pharma Research Lab

Author Info: (1) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (2) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (3) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (4) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (5) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (6) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (7) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (8) Aix Marseille UniversitŽ, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France. (9) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (10) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (11) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (12) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (13) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (14) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (15) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (16) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (17) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (18) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (19) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (20) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (21) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (22) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (23) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (24) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (25) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (26) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (27) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (28) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (29) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (30) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (31) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (32) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (33) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. (34) Innate Pharma Research Laboratories, Innate Pharma, Marseille, France. Aix Marseille UniversitŽ, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France. APHM, H™pital de la Timone, Marseille-Immunop™le Profiling Platform, Marseille, France. Paris-Saclay Cancer Cluster, Le Kremlin-Bictre, France. UniversitŽ Paris-Saclay, Gustave Roussy, INSERM, PrŽdicteurs molŽculaires et nouvelles cibles en oncologie, 94800, Villejuif, France.

Author Info: (1) KTH Royal Institute of Technology, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, Stockholm, Sweden. Strike Pharma AB, Up

Author Info: (1) KTH Royal Institute of Technology, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, Stockholm, Sweden. Strike Pharma AB, Uppsala, Sweden. (2) Strike Pharma AB, Uppsala, Sweden. Department of Pharmacy, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. (3) Strike Pharma AB, Uppsala, Sweden. (4) Strike Pharma AB, Uppsala, Sweden. (5) Strike Pharma AB, Uppsala, Sweden. Department of Pharmacy, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. (6) Strike Pharma AB, Uppsala, Sweden. Department of Pharmacy, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. (7) Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden. (8) KTH Royal Institute of Technology, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, Stockholm, Sweden. Science for Life Laboratory, Drug Discovery and Development, Stockholm, Sweden. (9) KTH Royal Institute of Technology, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, Stockholm, Sweden. Science for Life Laboratory, Drug Discovery and Development, Stockholm, Sweden. (10) KTH Royal Institute of Technology, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, Stockholm, Sweden. Science for Life Laboratory, Drug Discovery and Development, Stockholm, Sweden. (11) KTH Royal Institute of Technology, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, Stockholm, Sweden. Science for Life Laboratory, Drug Discovery and Development, Stockholm, Sweden. (12) KTH Royal Institute of Technology, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, Stockholm, Sweden. Science for Life Laboratory, Drug Discovery and Development, Stockholm, Sweden. (13) Strike Pharma AB, Uppsala, Sweden. SciCross AB, Skšvde, Sweden. (14) KTH Royal Institute of Technology, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, Stockholm, Sweden. johanr@biotech.kth.se. Strike Pharma AB, Uppsala, Sweden. johanr@biotech.kth.se. (15) Strike Pharma AB, Uppsala, Sweden. sara.mangsbo@farmaci.uu.se. Department of Pharmacy, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. sara.mangsbo@farmaci.uu.se.